Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults (source: Medical News Today)
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demons… (source: Medical News Today) – RSS news feeds and Widgets on Feedzilla.com
More From Stop Anxiety
- Case Western School Of Medicine Receives RWJF Grant To Establish A Public Health Research Network (source: Medical News Today)
- Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe (source: Medical News Today)
- Innovative Therapy That Offers New Hope For Borderline Personality Disorder (source: Medical News Today)
- Seaside Therapeutics Initiates Clinical Development Of Novel Treatment For Fragile X Syndrome (source: Medical News Today)
- Increased Risk Of Motor Vehicle Crashes For Young Drivers Who Engage In Self-Harm (DRIVE Study) (source: Medical News Today)
